Emily S. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emily S. Miller has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
William A. Grobman
Northwestern University Feinberg School of Medicine, Chicago, IL
5 shared publications- William A. Grobman
The Warren Alpert Medical School of Brown University, Department of Obstetrics and Gynecology
5 shared publications - Kate Swanson
Department of Obstetrics, Gynecology, and Reproductive Sciences Division of Maternal‐Fetal Medicine University of California, San Francisco San Francisco California USA
3 shared publications - Moeun Son
Division of Maternal‐Fetal Medicine Department of Obstetrics and Gynecology Weill Cornell Medical College New York New York USA
3 shared publications - Allie Sakowicz
Department of Obstetrics & Gynecology, Wake Forest University School of Medicine, Winston-Salem, NC (Sakowicz)
2 shared publications Ann Borders
2 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S403-S404
688: Do psychotropic medications reduce inflammation in women with antenatal depression/anxiety?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S403-S404
688: Do psychotropic medications reduce inflammation in women with antenatal depression/anxiety?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S404
689: Does maternal inflammation mediate the relationship between antenatal depression and adverse pregnancy outcomes?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S404
689: Does maternal inflammation mediate the relationship between antenatal depression and adverse pregnancy outcomes?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S393
670: Is there an association between attempted external cephalic version and neonatal morbidity?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S393
670: Is there an association between attempted external cephalic version and neonatal morbidity?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S322
546: A comparison of maternal and neonatal outcomes with two diagnostic strategies for gestational diabetes
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S322
546: A comparison of maternal and neonatal outcomes with two diagnostic strategies for gestational diabetes
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S212
350: Preterm birth prediction with transvaginal cervical length and uterocervical angle measurements
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S212
350: Preterm birth prediction with transvaginal cervical length and uterocervical angle measurements
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S405
691: The association between maternal peripheral blood inflammatory cytokines and depressive symptomatology
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S405
691: The association between maternal peripheral blood inflammatory cytokines and depressive symptomatology
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S400
682: Can venous cord gas predict fetal acidemia?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S400
682: Can venous cord gas predict fetal acidemia?
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S404-S405
690: The association of SSRIs with inflammatory cytokines in maternal cerebrospinal fluid, peripheral blood and umbilical cord blood
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S404-S405
690: The association of SSRIs with inflammatory cytokines in maternal cerebrospinal fluid, peripheral blood and umbilical cord blood
- 1 July 2016
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 34 (02) , 164-168
Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure?
Objective Determine whether the indication for intrauterine balloon tamponade (IUBT) is associated with failure rates. Study Design Cohort study of women who underwent IUBT for postpartum hemorrhage (PPH) from 2007 to 2014. The indication was categorized as uterine atony or placental-site bleeding. Primary outcome was IUBT failure, defined as the need for uterine artery embolization or hysterectomy. Secondary outcomes were estimated blood loss (EBL) after balloon placement, transfusion of red blood cells (RBC), transfusion of fresh frozen plasma (FFP) and/or cryoprecipitate, and intensive care unit (ICU) admission. Results 306 women underwent IUBT: 241 (78.8%) for uterine atony and 65 (21.2%) for placental site bleeding. Overall, 67 (21.9%) women experienced IUBT failure. The frequency of failure was similar in those with uterine atony compared with those with placental-site bleeding (21.2 vs 24.6%, p = 0.55). This finding persisted after adjusting for potential confounders (aOR, 0.97; 95% CI, 0.48–1.99). Median EBL after balloon placement (190 [interquartile range, 93–375] vs 195 [interquartile range, 103–500] mL, p = 0.46), and frequencies of RBC transfusion (62.7 vs 66.2%, p = 0.60), FFP and/or cryoprecipitate transfusion (25.3 vs 33.8%, p = 0.17), and ICU admission (12.4 vs 16.9%, p = 0.35) were also similar. Conclusion IUBT was similarly effective for managing PPH from uterine atony or placental-site bleeding. This study was presented at the 36th annual meeting of the Society for Maternal–Fetal Medicine, Atlanta, GA, February 1 to 6, 2016.
- 1 July 2016
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 34 (02) , 164-168
Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure?
Objective Determine whether the indication for intrauterine balloon tamponade (IUBT) is associated with failure rates. Study Design Cohort study of women who underwent IUBT for postpartum hemorrhage (PPH) from 2007 to 2014. The indication was categorized as uterine atony or placental-site bleeding. Primary outcome was IUBT failure, defined as the need for uterine artery embolization or hysterectomy. Secondary outcomes were estimated blood loss (EBL) after balloon placement, transfusion of red blood cells (RBC), transfusion of fresh frozen plasma (FFP) and/or cryoprecipitate, and intensive care unit (ICU) admission. Results 306 women underwent IUBT: 241 (78.8%) for uterine atony and 65 (21.2%) for placental site bleeding. Overall, 67 (21.9%) women experienced IUBT failure. The frequency of failure was similar in those with uterine atony compared with those with placental-site bleeding (21.2 vs 24.6%, p = 0.55). This finding persisted after adjusting for potential confounders (aOR, 0.97; 95% CI, 0.48–1.99). Median EBL after balloon placement (190 [interquartile range, 93–375] vs 195 [interquartile range, 103–500] mL, p = 0.46), and frequencies of RBC transfusion (62.7 vs 66.2%, p = 0.60), FFP and/or cryoprecipitate transfusion (25.3 vs 33.8%, p = 0.17), and ICU admission (12.4 vs 16.9%, p = 0.35) were also similar. Conclusion IUBT was similarly effective for managing PPH from uterine atony or placental-site bleeding. This study was presented at the 36th annual meeting of the Society for Maternal–Fetal Medicine, Atlanta, GA, February 1 to 6, 2016.
- 30 May 2016
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 34 (01) , 70-73
The Association between the Intertwin Interval and Adverse Neonatal Outcomes
Objective Previous data examining the association between the interval between the delivery of the first and second twin (intertwin interval) and adverse neonatal outcomes are conflicting. We sought to evaluate whether intertwin interval is associated with adverse neonatal outcomes for the second twin in a contemporary U. S. cohort. Methods This is a cohort study of women who delivered twins at or after 32 weeks gestation between 2006 and 2014 and whose first twin was delivered vaginally vertex. The intertwin interval was dichotomized as < 10 minutes or ≥ 10 minutes. Adverse outcomes included arterial cord pH ≤ 7.1, admission to the neonatal intensive care unit, respiratory distress, intraventricular hemorrhage, and death. Results Of the 171 subjects, 61 (35.7%) had an intertwin interval of ≥ 10 minutes. There were no differences in maternal characteristics. Intertwin interval of ≥ 10 minutes was associated with an increased frequency of arterial pH ≤ 7.1 (22.0 vs. 8.2%, p = 0.03), which persisted after adjusting for confounders (adjusted odds ratio, 2.94; 95% confidence interval, 1.04–8.33). Other adverse outcomes did not differ. Conclusion Intertwin interval of ≥ 10 minutes was associated with increased frequency of arterial pH ≤ 7.1 in the second twin, but no other adverse neonatal outcomes.
- 30 May 2016
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 34 (01) , 70-73
The Association between the Intertwin Interval and Adverse Neonatal Outcomes
Objective Previous data examining the association between the interval between the delivery of the first and second twin (intertwin interval) and adverse neonatal outcomes are conflicting. We sought to evaluate whether intertwin interval is associated with adverse neonatal outcomes for the second twin in a contemporary U. S. cohort. Methods This is a cohort study of women who delivered twins at or after 32 weeks gestation between 2006 and 2014 and whose first twin was delivered vaginally vertex. The intertwin interval was dichotomized as < 10 minutes or ≥ 10 minutes. Adverse outcomes included arterial cord pH ≤ 7.1, admission to the neonatal intensive care unit, respiratory distress, intraventricular hemorrhage, and death. Results Of the 171 subjects, 61 (35.7%) had an intertwin interval of ≥ 10 minutes. There were no differences in maternal characteristics. Intertwin interval of ≥ 10 minutes was associated with an increased frequency of arterial pH ≤ 7.1 (22.0 vs. 8.2%, p = 0.03), which persisted after adjusting for confounders (adjusted odds ratio, 2.94; 95% confidence interval, 1.04–8.33). Other adverse outcomes did not differ. Conclusion Intertwin interval of ≥ 10 minutes was associated with increased frequency of arterial pH ≤ 7.1 in the second twin, but no other adverse neonatal outcomes.